Elevance Health Inc Market Cap ($90.81 Billion)
Market Cap & Net Worth: Elevance Health Inc (ELV)
Elevance Health Inc market cap. Elevance Health Inc (NYSE:ELV) has a market capitalization of $90.81 Billion ($90.81 Billion) as of November 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #286 globally and #147 in its home market, demonstrating a -5.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elevance Health Inc's stock price $420.07 by its total outstanding shares 216869290 (216.87 Million). Also see Elevance Health Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Elevance Health Inc Market Cap History (2015–2026)
Elevance Health Inc market cap history from 2015 to 2026. Data shows growth from $26.96 Billion to $91.10 Billion (11.05% CAGR). Check ELV stock price and chart for real-time trading data and today's change.
Index Memberships
Elevance Health Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.47 Trillion | 0.23% | #118 of 503 |
Weight: Elevance Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Elevance Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elevance Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Elevance Health Inc (ELV) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.38x
Elevance Health Inc's market cap is 0.38 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.43x
Elevance Health Inc's market cap is 13.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.34 Billion | $84.98 Billion | $2.47 Billion | 0.33x | 11.48x |
| 2017 | $44.99 Billion | $90.04 Billion | $3.84 Billion | 0.50x | 11.71x |
| 2018 | $53.13 Billion | $92.11 Billion | $3.75 Billion | 0.58x | 14.17x |
| 2019 | $61.81 Billion | $104.21 Billion | $4.81 Billion | 0.59x | 12.86x |
| 2020 | $66.60 Billion | $121.87 Billion | $4.57 Billion | 0.55x | 14.57x |
| 2021 | $97.31 Billion | $138.64 Billion | $6.10 Billion | 0.70x | 15.94x |
| 2022 | $108.82 Billion | $156.59 Billion | $5.89 Billion | 0.69x | 18.46x |
| 2023 | $101.32 Billion | $171.34 Billion | $5.99 Billion | 0.59x | 16.92x |
| 2024 | $80.00 Billion | $176.81 Billion | $5.98 Billion | 0.45x | 13.38x |
| 2025 | $76.02 Billion | $199.12 Billion | $5.66 Billion | 0.38x | 13.43x |
Competitor Companies of ELV by Market Capitalization
Companies near Elevance Health Inc in the global market cap rankings as of November 1, 2026. Also see ELV total asset value for a full breakdown of the balance sheet.
Key companies related to Elevance Health Inc by market ranking:
- UnitedHealth Group Incorporated (NYSE:UNH): Ranked #41 globally with a market cap of $369.59 Billion USD.
- CVS Health Corp (NYSE:CVS): Ranked #251 globally with a market cap of $101.04 Billion USD.
- Cigna Corp (NYSE:CI): Ranked #364 globally with a market cap of $77.85 Billion USD.
- Humana Inc (NYSE:HUM): Ranked #613 globally with a market cap of $44.10 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41 | UnitedHealth Group Incorporated | NYSE:UNH | $369.59 Billion | $406.97 |
| #251 | CVS Health Corp | NYSE:CVS | $101.04 Billion | $90.25 |
| #364 | Cigna Corp | NYSE:CI | $77.85 Billion | $298.23 |
| #613 | Humana Inc | NYSE:HUM | $44.10 Billion | $414.50 |
Market Capitalization of Elevance Health Inc (2015–2026)
Market capitalization of Elevance Health Inc from 2015 to today. Between 2015 and today, Elevance Health Inc's market cap moved from $26.96 Billion to $ 91.10 Billion, with a yearly change of 11.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $91.10 Billion | +19.83% |
| 2025 | $76.02 Billion | -4.97% |
| 2024 | $80.00 Billion | -21.04% |
| 2023 | $101.32 Billion | -6.89% |
| 2022 | $108.82 Billion | +11.83% |
| 2021 | $97.31 Billion | +46.12% |
| 2020 | $66.60 Billion | +7.74% |
| 2019 | $61.81 Billion | +16.33% |
| 2018 | $53.13 Billion | +18.11% |
| 2017 | $44.99 Billion | +58.72% |
| 2016 | $28.34 Billion | +5.15% |
| 2015 | $26.96 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Elevance Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $90.81 Billion USD |
| MoneyControl | $90.81 Billion USD |
| MarketWatch | $90.81 Billion USD |
| marketcap.company | $90.81 Billion USD |
| Reuters | $90.81 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more